Tags

Type your tag names separated by a space and hit enter

Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China.
Ann Med. 2023 Dec; 55(1):672-679.AM

Abstract

OBJECTIVE

This population-based study aimed to determine the hesitancy and willingness to pay (WTP) for the booster dose of a coronavirus disease (COVID-19) vaccine among patients with cancer in Taizhou, China.

PATIENTS AND METHODS

A self-administered online questionnaire was administered to patients with cancer in Taizhou, China. The chi-square test, binary logistic regression model were used to evaluate the WTP for the booster dose of a COVID-19 vaccine. The minimum sample size was 218, determined by G*Power software (latest ver. 3.1.9.7). A total of 354 patients received the survey, and 256 (72.3%) patients responded.

RESULTS

Overall, 69.9% (179/256) of respondents were willing to pay for the booster dose, and 78.8% (141/179) of these patients were willing to pay 1-99 CNY. Furthermore, 50.4% (129/256) of respondents were hesitant to receive a COVID-19 vaccine. Being unhesitant was significantly associated with WTP for the booster dose (aOR: 3.040; 95% CI: 1.669-5.540).

CONCLUSION

Hesitant patients with cancer had a lower WTP for the booster dose against COVID-19 than non-hesitant participants. These results imply that further health education programmes are essential to decrease the hesitancy of patients with cancer and enhance booster dose vaccination rates for public health improvements.KEY MESSAGESOur research showed that 70% of patients with cancer are willing to pay for the booster dose of the COVID-19 vaccine, and most are willing to pay less than 100 CNY, and this result reflects the economic value and affordability of the third dose of vaccination.COVID-19 vaccine-hesitant patients with cancer had a lower willingness to pay for a booster dose against COVID-19 than non-hesitant participants and few patients are still unwilling to pay among patients do not hesitate to receive the third dose.Therefore, promoting willingness to pay among oncology patients and addressing vaccine hesitancy remains key.

Links

PMC Free PDF

Authors+Show Affiliations

An JX
Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Lin XQ
Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Xie BJ
Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Tung TH
Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Zhu JS
Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.

MeSH

HumansCOVID-19 VaccinesVaccination HesitancyCOVID-19NeoplasmsChinaVaccination

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36840655

Citation

An, Jia-Xiang, et al. "Relationship Between COVID-19 Vaccine Hesitancy and Willingness to Pay for the Booster Dose of COVID-19 Vaccine of Oncology Patients in Taizhou, China." Annals of Medicine, vol. 55, no. 1, 2023, pp. 672-679.
An JX, Lin XQ, Xie BJ, et al. Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China. Ann Med. 2023;55(1):672-679.
An, J. X., Lin, X. Q., Xie, B. J., Tung, T. H., & Zhu, J. S. (2023). Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China. Annals of Medicine, 55(1), 672-679. https://doi.org/10.1080/07853890.2023.2165705
An JX, et al. Relationship Between COVID-19 Vaccine Hesitancy and Willingness to Pay for the Booster Dose of COVID-19 Vaccine of Oncology Patients in Taizhou, China. Ann Med. 2023;55(1):672-679. PubMed PMID: 36840655.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China. AU - An,Jia-Xiang, AU - Lin,Xiao-Qing, AU - Xie,Bo-Jian, AU - Tung,Tao-Hsin, AU - Zhu,Jian-Sheng, PY - 2023/2/25/entrez PY - 2023/2/26/pubmed PY - 2023/2/26/medline KW - COVID-19 KW - booster dose vaccine KW - hesitancy KW - patients with cancer KW - willingness to pay SP - 672 EP - 679 JF - Annals of medicine JO - Ann Med VL - 55 IS - 1 N2 - OBJECTIVE: This population-based study aimed to determine the hesitancy and willingness to pay (WTP) for the booster dose of a coronavirus disease (COVID-19) vaccine among patients with cancer in Taizhou, China. PATIENTS AND METHODS: A self-administered online questionnaire was administered to patients with cancer in Taizhou, China. The chi-square test, binary logistic regression model were used to evaluate the WTP for the booster dose of a COVID-19 vaccine. The minimum sample size was 218, determined by G*Power software (latest ver. 3.1.9.7). A total of 354 patients received the survey, and 256 (72.3%) patients responded. RESULTS: Overall, 69.9% (179/256) of respondents were willing to pay for the booster dose, and 78.8% (141/179) of these patients were willing to pay 1-99 CNY. Furthermore, 50.4% (129/256) of respondents were hesitant to receive a COVID-19 vaccine. Being unhesitant was significantly associated with WTP for the booster dose (aOR: 3.040; 95% CI: 1.669-5.540). CONCLUSION: Hesitant patients with cancer had a lower WTP for the booster dose against COVID-19 than non-hesitant participants. These results imply that further health education programmes are essential to decrease the hesitancy of patients with cancer and enhance booster dose vaccination rates for public health improvements.KEY MESSAGESOur research showed that 70% of patients with cancer are willing to pay for the booster dose of the COVID-19 vaccine, and most are willing to pay less than 100 CNY, and this result reflects the economic value and affordability of the third dose of vaccination.COVID-19 vaccine-hesitant patients with cancer had a lower willingness to pay for a booster dose against COVID-19 than non-hesitant participants and few patients are still unwilling to pay among patients do not hesitate to receive the third dose.Therefore, promoting willingness to pay among oncology patients and addressing vaccine hesitancy remains key. SN - 1365-2060 UR - https://www.unboundmedicine.com/medline/citation/36840655/Relationship_between_COVID_19_vaccine_hesitancy_and_willingness_to_pay_for_the_booster_dose_of_COVID_19_vaccine_of_oncology_patients_in_Taizhou_China_ DB - PRIME DP - Unbound Medicine ER -